Reactions are mixed about the implications – and any possible political fallout – of President Trump’s announcement last week that the administration would end the Affordable Care Act’s cost-sharing reduction payments to insurers, as well as his executive order to ease restrictions on what types of health plans insurers can offer on the exchanges.

Scott Behrens, vice president, ERISA compliance attorney at Lockton Compliance Services, writes that ending the CSR payments could further destabilize the individual health insurance market, “though it might also inject additional urgency in Congress to develop and pass legislation that creates long term stability.”

“The announcement explains that the administration believes continuing CSRs without an express authorization from Congress is unconstitutional,” Behrens writes. “In other words, the Trump Administration is telling Congress ‘the ball is in your court.’”